[Question] API source — what am I missing here
API source — what am I missing here, and I want the answer with the reasoning attached rather than just the conclusion.
Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot.
Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.
Asked which facility and got a name straight away. Looked it up, found the registration, felt considerably better about the whole thing.
If two or three other people have done the same thing we might actually learn something. Alone it is an anecdote.
best — the order this archive was captured in
The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes.
Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material. Ask which you are being shown.
potency testing on the finished preparation is the thing to ask for
a telehealth intake that asks nothing has told you what it is
Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.
I would not read the price difference as a quality signal. Most of it is the consultation model, not the vial.
Who is the prescriber, and are they the same organisation as the pharmacy?
shortage status changes and the whole arrangement changes with it
Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label.
salt forms are the recurring argument and the answer is boring
The intake asked me three questions and none of them were about my history. That told me everything I needed to know about the model.
if a clinic will not name the facility, that is your answer
Was there potency testing on the finished preparation, or only on the starting material?
Compounded preparations are not approved products and carry no bioequivalence claim. That is a statement about regulatory category, not about quality.
Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.
Is the compound still on the shortage list where you are?
Not convinced. You are comparing a compounded concentration with a branded one and assuming they match.
Kept the label from every vial. When the shortage status changed, having the paper trail made the conversation much shorter.
Asked for potency testing on the finished preparation. They had it. I had assumed they would not.
Asked for potency testing on the finished preparation.
Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.
That is not what patient-specific means. It refers to the prescription, not to a customisation of the formula.
- 1Potency and sterility testing on the finished preparation are separate from…6 comments in this branch · started by u/vikram_mbeki